SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-036698
Filing Date
2018-06-29
Accepted
2018-06-29 16:31:35
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv497001_10q.htm 10-Q 564788
2 EXHIBIT 31.1 tv497001_ex31-1.htm EX-31.1 9624
3 EXHIBIT 31.2 tv497001_ex31-2.htm EX-31.2 9533
4 EXHIBIT 32.1 tv497001_ex32-1.htm EX-32.1 4881
  Complete submission text file 0001144204-18-036698.txt   4748574

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20180331.xml EX-101.INS 1016640
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20180331.xsd EX-101.SCH 53269
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20180331_cal.xml EX-101.CAL 35339
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20180331_def.xml EX-101.DEF 315112
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20180331_lab.xml EX-101.LAB 377273
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20180331_pre.xml EX-101.PRE 357593
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 18929653
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1